AIM: To investigate the associations between CDH1 gene polymorphisms and gastric cancer (GC) risk predisposition. METHODS: We analyzed four CDH1 polymorphisms (+54 T>C, -160 C>A, -616 G>C, -3159 T>C) in an Omani population, by extraction of genomic DNA from the peripheral blood of 192 patients with GC and 170 control participants and performed CDH1 genotyping using DNA sequencing. RESULTS: CDH1 -160 -AA genotype was associated with an increased risk of GC (OR = 3.6, 95% CI: 1.1-11.8) (P = 0.03). There was no significant association between the other polymorphisms and GC risk. The haplotype analysis of +54 T>C, -160 C>A, -616 G>C, -3159 T>C genotypes revealed that the OR of CCGC and CAGC haplotypes was 1.5 (95% CI: 0.7-3.5) and 1.5 (95% CI: 0.2-3.0), but did not reach statistical significance. CONCLUSION: The current study suggests that the -160 AA genotype was associated with an increased risk of GC in Oman.
AIM: To investigate the associations between CDH1 gene polymorphisms and gastric cancer (GC) risk predisposition. METHODS: We analyzed four CDH1 polymorphisms (+54 T>C, -160 C>A, -616 G>C, -3159 T>C) in an Omani population, by extraction of genomic DNA from the peripheral blood of 192 patients with GC and 170 control participants and performed CDH1 genotyping using DNA sequencing. RESULTS:CDH1 -160 -AA genotype was associated with an increased risk of GC (OR = 3.6, 95% CI: 1.1-11.8) (P = 0.03). There was no significant association between the other polymorphisms and GC risk. The haplotype analysis of +54 T>C, -160 C>A, -616 G>C, -3159 T>C genotypes revealed that the OR of CCGC and CAGC haplotypes was 1.5 (95% CI: 0.7-3.5) and 1.5 (95% CI: 0.2-3.0), but did not reach statistical significance. CONCLUSION: The current study suggests that the -160 AA genotype was associated with an increased risk of GC in Oman.
Authors: L C Li; R M Chui; M Sasaki; K Nakajima; G Perinchery; H C Au; D Nojima; P Carroll; R Dahiya Journal: Cancer Res Date: 2000-02-15 Impact factor: 12.701
Authors: Paul D P Pharoah; Carla Oliveira; José Carlos Machado; Gisella Keller; Holger Vogelsang; Holger Laux; Karl-Friedrich Becker; Heidi Hahn; Suzanne M Paproski; Lindsay A Brown; Carlos Caldas; David Huntsman Journal: Int J Cancer Date: 2002-09-10 Impact factor: 7.396
Authors: Kenji Shibuya; Colin D Mathers; Cynthia Boschi-Pinto; Alan D Lopez; Christopher J L Murray Journal: BMC Cancer Date: 2002-12-26 Impact factor: 4.430
Authors: Sydney L Stoops; A Scott Pearson; Connie Weaver; Alex G Waterson; Emily Days; Chris Farmer; Suzanne Brady; C David Weaver; R Daniel Beauchamp; Craig W Lindsley Journal: ACS Chem Biol Date: 2011-02-09 Impact factor: 5.100